Biomedical research at Oslo University Hospital
Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.
Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.
Click here to see hierarchical division and subunit overview
Summary of publications:
Publications (original articles or review articles) published in 2020 from OUS - Department of Nephrology Rikshospitalet (Div SIMT)
21 publications found
The association of living donor source with patient and graft survival among kidney transplant recipients in the ERA-EDTA Registry - a retrospective study
Transpl Int, 34 (1), 76-86
DOI 10.1111/tri.13759, PubMed 33022814
Severe Mycophenolate Intoxication in a Solid Organ Transplant Recipient-No Intervention Actually Needed
Transplant Direct, 6 (10), e609
DOI 10.1097/TXD.0000000000001058, PubMed 33062842
Relative and absolute cancer risks among Nordic kidney transplant recipients-a population-based study
Transpl Int, 33 (12), 1700-1710
DOI 10.1111/tri.13734, PubMed 32896035
Five decades with grandparent donors: The Norwegian strategy and experience
Pediatr Transplant, 24 (6), e13751
DOI 10.1111/petr.13751, PubMed 32485019
Marine n-3 fatty acid consumption in a Norwegian renal transplant cohort: Comparison of a food frequency questionnaire with plasma phospholipid marine n-3 levels
PLoS One, 15 (12), e0244089
DOI 10.1371/journal.pone.0244089, PubMed 33332416
Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids
Theranostics, 10 (19), 8665-8676
DOI 10.7150/thno.46123, PubMed 32754270
GFR in Healthy Aging: an Individual Participant Data Meta-Analysis of Iohexol Clearance in European Population-Based Cohorts
J Am Soc Nephrol, 31 (7), 1602-1615
DOI 10.1681/ASN.2020020151, PubMed 32499396
Prevalence of multiple sclerosis in rural and urban districts in Telemark county, Norway
Mult Scler Relat Disord, 45, 102352
DOI 10.1016/j.msard.2020.102352, PubMed 32707528
Intrauterine growth restriction, preterm birth and risk of end-stage renal disease during the first 50 years of life
Nephrol Dial Transplant, 35 (7), 1157-1163
DOI 10.1093/ndt/gfaa001, PubMed 32040151
Intrauterine Growth Restriction and Risk of Diverse Forms of Kidney Disease during the First 50 Years of Life
Clin J Am Soc Nephrol, 15 (10), 1413-1423
DOI 10.2215/CJN.04080320, PubMed 32816833
Fasting Status and Circadian Variation Must be Considered When Performing AUC-based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant Recipients
Clin Transl Sci, 13 (6), 1327-1335
DOI 10.1111/cts.12833, PubMed 32652886
Tacrolimus Area Under the Concentration Versus Time Curve Monitoring, Using Home-Based Volumetric Absorptive Capillary Microsampling
Ther Drug Monit, 42 (3), 407-414
DOI 10.1097/FTD.0000000000000697, PubMed 31479042
Predicting donor, recipient and graft survival in living donor kidney transplantation to inform pretransplant counselling: the donor and recipient linked iPREDICTLIVING tool - a retrospective study
Transpl Int, 33 (7), 729-739
DOI 10.1111/tri.13580, PubMed 31970822
Increased long-term risk for hypertension in kidney donors - a retrospective cohort study
Transpl Int, 33 (5), 536-543
DOI 10.1111/tri.13576, PubMed 31958170
Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics
Transpl Int, 34 (1), 27-48
DOI 10.1111/tri.13783, PubMed 33135259
Pharmacodynamic assessment of mycophenolic acid in resting and activated target cell population during the first year after renal transplantation
Br J Clin Pharmacol, 86 (6), 1100-1112
DOI 10.1111/bcp.14218, PubMed 31925806
Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor
Virol J, 17 (1), 5
DOI 10.1186/s12985-019-1275-9, PubMed 31924245
A Simplified Iohexol-Based Method to Measure Renal Function in Sheep Models of Renal Disease
Biology (Basel), 9 (9)
DOI 10.3390/biology9090259, PubMed 32878167
Endothelial function after pancreas transplantation-A single-center observational study
Clin Transplant, 34 (3), e13815
DOI 10.1111/ctr.13815, PubMed 32027399
Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients
PLoS One, 15 (12), e0243759
DOI 10.1371/journal.pone.0243759, PubMed 33326471
Prednisolone and Prednisone Pharmacokinetics in Adult Renal Transplant Recipients
Ther Drug Monit (in press)
DOI 10.1097/FTD.0000000000000835, PubMed 33181621